These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15921865)

  • 1. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
    Haines CJ; Xing SM; Park KH; Holinka CF; Ausmanas MK
    Maturitas; 2005; 52(3-4):264-76. PubMed ID: 15921865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia menopause (PAM) study.
    Tan D; Haines CJ; Limpaphayom KK; Holinka CF; Ausmanas MK
    Maturitas; 2005 Sep; 52(1):35-51. PubMed ID: 16211697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study.
    Limpaphayom KK; Darmasetiawan MS; Hussain RI; Burriss SW; Holinka CF; Ausmanas MK
    Climacteric; 2006 Jun; 9(3):204-14. PubMed ID: 16766434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnic differences in levels of bone and cartilage biomarkers and hormonal responsiveness in nine groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Holinka CF; Christiansen C; Tian XW; Ausmanas MK
    Climacteric; 2008 Feb; 11(1):44-54. PubMed ID: 18202964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
    Taechakraichana N; Holinka CF; Haines CJ; Subramaniam R; Tian XW; Ausmanas MK
    Climacteric; 2007 Jun; 10(3):225-37. PubMed ID: 17487649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.
    Kagan R; Abreu P; Andrews E
    Postgrad Med; 2018 Nov; 130(8):687-693. PubMed ID: 30280946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women.
    Utian WH; Gass ML; Pickar JH
    Menopause; 2004; 11(3):306-14. PubMed ID: 15167310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of conjugated estrogens/bazedoxifene on lipid and coagulation variables: a randomized placebo- and active-controlled trial.
    Skouby SO; Pan K; Thompson JR; Komm BS; Mirkin S
    Menopause; 2015 Jun; 22(6):640-9. PubMed ID: 25405570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study.
    Ausmanas MK; Holinka CF; Ling YS; Christiansen C
    Climacteric; 2007 Aug; 10(4):306-13. PubMed ID: 17653957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women.
    Huang AJ; Sawaya GF; Vittinghoff E; Lin F; Grady D
    Menopause; 2018 Nov; 25(11):1286-1290. PubMed ID: 30358724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    Osteoporos Int; 2005 Apr; 16(4):372-9. PubMed ID: 15654581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD; Durand-Carbajal M; Jiménez-Santana L; Lara-Reyes P; Seuc AH; Sánchez-Guerrero J
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1654-63. PubMed ID: 22127965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal symptoms in older women and the effects of treatment with hormone therapy.
    Barnabei VM; Grady D; Stovall DW; Cauley JA; Lin F; Stuenkel CA; Stefanick ML; Pickar JH
    Obstet Gynecol; 2002 Dec; 100(6):1209-18. PubMed ID: 12468165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
    Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Monteleone P; Benussi C; Bevilacqua G; Vacca F; Genazzani AR
    Maturitas; 2005 Feb; 50(2):91-7. PubMed ID: 15653005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
    Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
    Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial.
    Greendale GA; Reboussin BA; Hogan P; Barnabei VM; Shumaker S; Johnson S; Barrett-Connor E
    Obstet Gynecol; 1998 Dec; 92(6):982-8. PubMed ID: 9840563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.